Trials / Completed
CompletedNCT01765075
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to gather electrophysiological data using a multi-electrode mapping catheter during a clinically indicated cardiac ablation procedure for the treatment of persistent atrial fibrillation.
Conditions
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2013-01-10
- Last updated
- 2014-03-05
Locations
2 sites across 2 countries: Czechia, United Kingdom
Source: ClinicalTrials.gov record NCT01765075. Inclusion in this directory is not an endorsement.